Featured Content

Multiple-Dose Vial Heparin Related to Severe Allergic Reactions 3/20/2008

The FDA announced that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable drug heparin, commonly used before surgery as a blood-thinning agent, due to reports of serious allergic reactions and hypotension in patients who receive high "bolus" doses of the drug.

Related Content

Acute Pancreatitis: Risks, Causes, and Mortality in Older Adults

In the elderly, acute pancreatitis is most commonly caused by gallstones, is more likely to be severe, and is associated with higher mortality. 



Evaluation of Strategies to Improve the Treatment of Recurrent Clostridium difficile–Associated Disease

New methods for treating this common nosocomial infection are being implemented. 

Amikacin 250 mg/mL Injection

This semisynthetic aminoglycoside antibiotic is presently in short supply.

Hospital Superbug Deconstructed



Labeling Guidelines for Antipsychotics During Pregnancy

The labeling for all antipsychotics will be updated to include an enhanced pregnancy section. 

HEPARIN

Acute Coronary Syndromes 2/20/2007

Each day, nearly 2,500 Americans die of cardiovascular disease--representing an average of one death every 35 seconds.

Advertisement